PRUITT MICHAEL D (CEO, Chairman) purchased 46.4% of their position (1K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $1.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/29/2019ACC: 0001493152-19-008335
DirectorOfficer· CEO, Chairman
Since Aug 2018
+1K
Net shares
Net buyer
$1.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+500.00
Price / share
$1.16
Trade value
$580.00
% of position
23.2%
5/24/2019
2.15K→2.65K
Common Stock
Indirect
Shares
+500.00
Price / share
$1.10
Trade value
$550.00
% of position
18.8%
5/28/2019
2.65K→3.15K
Total
Net shares
+1K
Net value
$1.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/24/2019 | P · Purchase | +500.00 | $1.16 | $580.00 | 23.2% | 2.15K | 2.65K |
| Common Stock Indirect | 5/28/2019 | P · Purchase | +500.00 | $1.10 | $550.00 | 18.8% | 2.65K | 3.15K |
| Total | +1K | $1.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Series 1 Preferred Stock
IndirectShares owned330.00
Common Stock
IndirectShares owned15.46K
Common Stock
DirectShares owned17.26K
Total
17.26K direct·15.79K indirect33.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Series 1 Preferred Stock | 330.00 | Indirect |
| Common Stock | 15.46K | Indirect |
| Common Stock | 17.26K | Direct |
| Total | 33.05K | 17.26K direct·15.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported